Together We Can

You Can Make a Radical Difference

The Immunobiology Lab at MGH is currently conducting multiple clinical trials using Bacillus Calmette-Guérin (BCG), an inexpensive generic drug, as a treatment for advanced type 1 diabetes. The BCG clinical trial program has been underway for almost 10 years. To date, more than 230 patients with longstanding type 1 diabetes have been enrolled in BCG clinical trials. A 150-patient, randomized, placebo-controlled, Phase II clinical trial is currently fully enrolled and all patients have been followed for at least one year. 

Help us fund the groundbreaking research of Dr. Denise Faustman and the promise of reversal of Type 1 Diabetes!

This website uses cookies to ensure you get the best experience on our website.